Veraxa Biotech Holding AG (VRXA) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Veraxa Biotech Holding AG (VRXA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $299.8M, listed on NASDAQ, employing roughly 8 people, carrying a beta of 0.25 to the broader market. Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp. Led by Christoph Antz, public since 2026-06-09.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for VRXA as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →